Bioinvent ingår ytterligare ett samarbete med MSD

Ska utvärdera kombinationen av Bioinvents antikropp och MSD:s läkemedel hos patienter med avancerade solida tumörer.

AstraZeneca moves to brewery quarters in central Copenhagen

AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.

Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell

Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Michael Linnell, project...

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a well-advanced project...

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Genes from Neanderthals can affect the correct drug dosage

A fifth of all Europeans carry gene variants inherited from Neanderthals, which cause certain drugs to break down more slowly. This may have implications for th...

”Kriminella handlar allt mer med falska läkemedel”

Under coronapandemin har försäljningen av förfalskade läkemedel skiftat om till läkemedel och produkter för covid-19.

Mördarceller mot multipelt myelom – klinisk studie inledd

Immunterapibolaget XNK Therapeutics meddelar att den första patienten nu behandlats inom ramen för företagets kliniska fas II-studie inom multipelt myelom.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Aqilion rekryterar ny ansvarig för preklinisk utveckling

Bioteknikbolaget Aqilion har rekryterat Anneli Hällgren som ansvarig för preklinisk utveckling.

Hansas läkemedel minskade dialysbehov vid ovanlig sjukdom

Läkemedlet imlifidase kan leda till ökad överlevnad för patienter med goodpastures sjukdom.

Outsourcing som strategi för ökad trovärdighet

Idag, torsdag, pågår Life Science Swedens event Pharma Outsourcing på Stockholm Waterfront. Under en av föreläsningarna jämfördes för- och nackdelar med att ta ...

The Swedish Life Science Office: “We lost in both coordination and manpower”

Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...

“You discover one thing – and then 10 new questions arise”

COVID-19, diabetes, heart disease, and the impact of dog ownership on humans are just some of multitasker Tove Fall’s areas of research. However, her current fo...

Amorphous materials take centre stage when Orexo develops new formulations

Swift resolution but with maintained stability. Orexo’s new drug delivery platform tackles the problem of amorphous materials. “Our technology has the positive ...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Venomaid's rapid test aims to find the right snake bite treatment

Every six seconds, someone on our planet suffers a snake bite, and each time, a race against the clock begins. What kind of snake was it, and which antivenom ca...

An organ seldom in the spotlight – but utterly vital

The kidneys consist of more than 40 types of cells and have more functions in the body than most people know. Julie Williams leads AstraZeneca’s work in preclin...

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

”Vem ska jag tro på?”

Alternativa hälsoprofeter, antiinflammatorisk kost och möjliga tankevurpor hos skolmedicinare – det är något av vad Anna Törner resonerar kring i en krönika.

Virology professor on the threat from X: ”The next pandemic could be worse“

The question is not if, but when we will be affected by a new unknown virus that causes yet another pandemic. Are we sufficiently prepared? "Absolutely not!", r...

Krönika: Collaboration across borders

The Oresund region aims at becoming Europe’s microbiome Mecca

The Medicon Valley Alliance’s ambition: Skåne and the Copenhagen region will become world leaders in microbiome research.